Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2015 1
2019 1
2020 6
2021 3
2022 3
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
An Italian Real-World Study Highlights the Importance of Some Clinicopathological Characteristics Useful in Identifying Metastatic Breast Cancer Patients Resistant to CDK4/6 Inhibitors and Hormone Therapy.
Maltoni R, Roncadori A, Balzi W, Mazza M, Nicolini F, Palleschi M, Ulivi P, Bravaccini S. Maltoni R, et al. Among authors: nicolini f. Biomedicines. 2024 Feb 22;12(3):498. doi: 10.3390/biomedicines12030498. Biomedicines. 2024. PMID: 38540112 Free PMC article.
Immunotherapy of mesothelioma: the evolving change of a long-standing therapeutic dream.
Calabrò L, Bronte G, Grosso F, Cerbone L, Delmonte A, Nicolini F, Mazza M, Di Giacomo AM, Covre A, Lofiego MF, Crinò L, Maio M. Calabrò L, et al. Among authors: nicolini f. Front Immunol. 2024 Jan 8;14:1333661. doi: 10.3389/fimmu.2023.1333661. eCollection 2023. Front Immunol. 2024. PMID: 38259475 Free PMC article. Review.
Circulating hsa-miR-5096 predicts 18F-FDG PET/CT positivity and modulates somatostatin receptor 2 expression: a novel miR-based assay for pancreatic neuroendocrine tumors.
Bocchini M, Tazzari M, Ravaioli S, Piccinini F, Foca F, Tebaldi M, Nicolini F, Grassi I, Severi S, Calogero RA, Arigoni M, Schrader J, Mazza M, Paganelli G. Bocchini M, et al. Among authors: nicolini f. Front Oncol. 2023 May 23;13:1136331. doi: 10.3389/fonc.2023.1136331. eCollection 2023. Front Oncol. 2023. PMID: 37287922 Free PMC article.
The power of telemedicine to improve CAR-T cell therapy programs: lessons learned from COVID-19 pandemic.
Canale FA, Martino M, Porto G, Verduci C, Console G, Irrera G, Loteta B, Naso V, Pugliese M, Moscato T, Ferreri A, Nappi D, Nicolini F, Mazza M, Martinelli G, Cerchione C. Canale FA, et al. Among authors: nicolini f. Support Care Cancer. 2023 May 25;31(6):350. doi: 10.1007/s00520-023-07811-6. Support Care Cancer. 2023. PMID: 37227523 Free PMC article. Review.
Chimeric Antigen Receptor T-Cell Therapy: What We Expect Soon.
Martino M, Naso V, Loteta B, Canale FA, Pugliese M, Alati C, Musuraca G, Nappi D, Gaimari A, Nicolini F, Mazza M, Bravaccini S, Derudas D, Martinelli G, Cerchione C. Martino M, et al. Among authors: nicolini f. Int J Mol Sci. 2022 Nov 1;23(21):13332. doi: 10.3390/ijms232113332. Int J Mol Sci. 2022. PMID: 36362130 Free PMC article. Review.
Why the complications of COVID-19 patients differ in elderly and young cancer patients.
Bravaccini S, Nicolini F, Zanoni M, Gaimari A, Cerchione C, Maltoni R, Pirini F, Mazzotti L, Cortesi M, Ravaioli S, Tumedei MM, Mazza M. Bravaccini S, et al. Among authors: nicolini f. Transl Oncol. 2022 Dec;26:101541. doi: 10.1016/j.tranon.2022.101541. Epub 2022 Sep 12. Transl Oncol. 2022. PMID: 36119944 Free PMC article.
Lenalidomide enhances CD23.CAR T cell therapy in chronic lymphocytic leukemia.
Tettamanti S, Rotiroti MC, Giordano Attianese GMP, Arcangeli S, Zhang R, Banerjee P, Galletti G, McManus S, Mazza M, Nicolini F, Martinelli G, Ivan C, Veliz Rodriguez T, Barbaglio F, Scarfò L, Ponzoni M, Wierda W, Gandhi V, Keating M, Biondi A, Caligaris-Cappio F, Biagi E, Ghia P, Bertilaccio MTS. Tettamanti S, et al. Among authors: nicolini f. Leuk Lymphoma. 2022 Jul;63(7):1566-1579. doi: 10.1080/10428194.2022.2043299. Epub 2022 Mar 8. Leuk Lymphoma. 2022. PMID: 35259043 Free PMC article.
CART-Cell Therapy: Recent Advances and New Evidence in Multiple Myeloma.
Martino M, Canale FA, Alati C, Vincelli ID, Moscato T, Porto G, Loteta B, Naso V, Mazza M, Nicolini F, Ghelli Luserna di Rorà A, Simonetti G, Ronconi S, Ceccolini M, Musuraca G, Martinelli G, Cerchione C. Martino M, et al. Among authors: nicolini f. Cancers (Basel). 2021 May 27;13(11):2639. doi: 10.3390/cancers13112639. Cancers (Basel). 2021. PMID: 34072068 Free PMC article. Review.
17 results